XPO1/CRM1-Selective Inhibitors of Nuclear Export (SINE) reduce tumor spreading and improve overall survival in preclinical models of prostate cancer (PCa)
Giovanni Luca Gravina(University of L'Aquila), Claudio Festuccia(University of L'Aquila), Dilara McCauley(Karyopharm Therapeutics (United States)), Ernesto Di Cesare(University of L'Aquila), Sharon Shacham(Roche (Switzerland)), Yosef Landesman(Karyopharm Therapeutics (United States)), Andrea Lenzi(Canadian Obesity Network), Monica Tortoreto(Fondazione IRCCS Istituto Nazionale dei Tumori), Nadia Zaffaroni(Fondazione IRCCS Istituto Nazionale dei Tumori), Alessandro Addis(Fondazione IRCCS Istituto Nazionale dei Tumori), Michael Kauffman(Roche (Switzerland)), Andrea Mancini(Azienda Unità Sanitaria Locale Della Romagna)
Cited by 72
Related Papers
Isolation and <i>In vitro</i> Propagation of Tumorigenic Breast Cancer Cells with Stem/Progenitor Cell Properties
|Cancer Research|2005|1.7k
Human Bone Marrow–Derived Mesenchymal Stem Cells Do Not Undergo Transformation after Long-term<i>In vitro</i>Culture and Do Not Exhibit Telomere Maintenance Mechanisms
|Cancer Research|2007|702
Testosterone and Metabolic Syndrome: A Meta-Analysis Study
|The Journal of Sexual Medicine|2010|395
Type 2 diabetes mellitus and testosterone: a meta-analysis study
|International Journal of Andrology|2010|369